| Product Code: ETC066714 | Publication Date: Aug 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Australia Infectious Disease Point-of-care Testing Market was estimated at USD 189 Million in 2025 and is projected to reach USD 222 Million by 2032, growing at a CAGR of 2.3% from 2026 to 2032. This upward trajectory is fueled primarily by the increasing demand for rapid diagnostic tests, essential for timely patient management and infection control in diverse healthcare environments. Furthermore, the rise of telemedicine and the push towards decentralizing healthcare services are catalyzing further adoption of point-of-care testing (POCT) devices across the country.
This graph highlights how the Australia Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -0.3% | Expansion of manufacturing activities |
| 2022 | 5.2% | Expansion of commercial construction activities |
| 2023 | 5.0% | Growing urbanization and commercial development |
| 2024 | 2.8% | Expansion of commercial construction activities |
| 2025 | 1.7% | Increasing adoption of advanced technologies |
| 2026 | 2.4% | Rapid growth in telecom and data center sectors |
| 2027 | 2.6% | Expansion of transportation and logistics networks |
| 2028 | 2.6% | Increasing industrial infrastructure investments |
| 2029 | 2.9% | Increasing adoption of advanced technologies |
| 2030 | 3.0% | Government infrastructure modernization initiatives |
| 2031 | 2.9% | Expansion of manufacturing activities |
| 2032 | 2.6% | Expansion of commercial construction activities |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The Australian healthcare landscape is rapidly evolving, marked by a significant shift towards the adoption of point-of-care testing for infectious diseases. This demand is particularly pronounced in clinics and hospitals, where the need for timely diagnoses can critically influence patient outcomes. In remote communities, the accessibility of POCT devices enhances early disease detection and management, playing a vital role in public health strategies.
Moreover, the increasing prevalence of infectious diseases and outbreaks further intensifies the urgency for reliable diagnostic solutions. The integration of advanced technologies into POC testing devices is enabling healthcare professionals to deliver faster and more accurate results, thereby supporting effective infection control measures and better patient care.
Despite the promising growth outlook, the Australia Infectious Disease Point-of-care Testing Market faces several challenges. Primarily, issues surrounding test accuracy and user-friendliness are significant hurdles. Many POCT devices require regulatory approval to ensure compliance with stringent quality standards. Manufacturers must consistently innovate while adhering to these guidelines, which can complicate the product development lifecycle. Furthermore, healthcare providers are often cautious about integrating new tests unless proven reliable, slowing down the adoption rate.
Current trends indicate a strong push towards integrating digital technologies into point-of-care testing solutions. The adoption of mobile health applications and data analytics is transforming how healthcare professionals access and interpret testing results. Additionally, increased collaboration between public health authorities and private sectors is fostering innovation in testing methodologies, enhancing overall testing capabilities. This trend towards digital integration not only streamlines processes but also improves patient engagement and compliance.
Significant growth opportunities exist within the Australia Infectious Disease Point-of-care Testing Market, particularly through investments in remote and underserved areas. Expanding telehealth services creates a unique opening for deploying point-of-care tests, enhancing diagnostic access and improving health outcomes. Furthermore, ongoing innovations in testing technologies, such as multiplex assays and portable devices, present opportunities for manufacturers to capture a larger market share by meeting specific healthcare needs.
The Australian government is actively involved in shaping the landscape of infectious disease point-of-care testing through various initiatives. Policies are being crafted to improve the accessibility and affordability of diagnostic solutions, particularly in remote communities. Furthermore, government funding often supports research and development efforts aimed at enhancing the accuracy and reliability of testing devices. Such initiatives are pivotal in bolstering the national response to infectious disease outbreaks and ensuring a robust public health infrastructure.
Looking ahead to the period from 2026 to 2032, the Australia Infectious Disease Point-of-care Testing Market is expected to continue its growth trajectory driven by technological advancements and increasing healthcare demands. The ongoing shift towards patient-centric care will likely propel the development of more sophisticated POC devices. Furthermore, as health systems increasingly focus on early detection and management of infectious diseases, the integration of point-of-care testing into routine clinical practices will become more commonplace. This evolution will ultimately enhance healthcare delivery and patient outcomes across Australia.
Recent industry movements indicate a growing emphasis on developing multi-functional point-of-care testing devices capable of diagnosing multiple infectious diseases simultaneously. Research collaboration between public health organizations and technology firms is on the rise, aiming to expedite the introduction of these innovative solutions. Additionally, ongoing discussions surrounding regulatory frameworks are aimed at simplifying approval processes, thereby facilitating faster market entry for new products.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Infectious Disease Point-of-care Testing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Australia Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Australia Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.6 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F |
3.7 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Australia Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of infectious diseases in Australia |
4.2.2 Growing awareness about the benefits of point-of-care testing for infectious diseases |
4.2.3 Technological advancements in point-of-care testing devices |
4.2.4 Government initiatives to improve healthcare infrastructure and accessibility |
4.2.5 Rising demand for rapid and accurate diagnostic solutions |
4.3 Market Restraints |
4.3.1 High cost associated with point-of-care testing devices |
4.3.2 Limited availability of skilled healthcare professionals for conducting tests |
4.3.3 Regulatory challenges and compliance requirements for point-of-care testing products |
4.3.4 Concerns regarding the accuracy and reliability of point-of-care testing compared to traditional laboratory testing methods |
4.3.5 Competition from alternative diagnostic methods and technologies |
5 Australia Infectious Disease Point-of-care Testing Market Trends |
6 Australia Infectious Disease Point-of-care Testing Market, By Types |
6.1 Australia Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F |
6.1.3 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F |
6.1.4 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F |
6.1.5 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F |
6.1.6 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F |
6.1.7 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
6.2 Australia Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F |
6.2.3 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F |
6.2.4 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F |
6.2.5 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F |
6.3 Australia Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.3.3 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.4 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F |
6.3.5 Australia Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Australia Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Australia Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Australia Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Australia Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Adoption rate of point-of-care testing for infectious diseases in healthcare facilities |
8.2 Average turnaround time for obtaining test results using point-of-care testing devices |
8.3 Rate of reimbursement by healthcare payers for point-of-care testing services |
8.4 Number of research and development initiatives focused on enhancing point-of-care testing technologies |
8.5 Percentage of healthcare providers offering point-of-care testing services for infectious diseases |
9 Australia Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Australia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.2 Australia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F |
9.3 Australia Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Australia Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Australia Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025 |
10.2 Australia Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here